BOSTON SCIENTIFIC CORP — Director's Dealing 2018

Dec 4, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2018-12-01

Reporting Person: Wang Xin Warren (SVP and Pres, Asia Pacific)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-01	Common Stock	M	2025.0000	$0.0000	Acquired	97573.0000	Direct
2018-12-01	Common Stock	F	912.0000	$37.6700	Disposed	96661.0000	Direct
2018-12-03	Common Stock	S	10000.0000	$37.9994	Disposed	86661.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-01	Deferred Stock Units	$	M	2025.0000	Disposed	2020-12-01	Common Stock (2025.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available.

F3: This transaction was effected pursuant to a pre-established Rule 10b5-1 trading plan.

F4: Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $37.8201 to $38.20, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

F5: Shares of common stock will be issued to the reporting person in five equal annual installments beginning on December 1, 2016, the first anniversary of the date of grant.